Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Thorax|October 18, 2005
Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary careD D Creer, J P Dilworth, S H Gillespie, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1994
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogensS G Amyes, D R Baird, D W Crook, et al.
Lancet (London, England)|November 24, 2004
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trialC Chintu, G J Bhat, A S Walker, et al.
Thorax|August 7, 2007
Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosisR A M Breen, S M Barry, C J Smith, et al.
BMC Medicine|May 22, 2018
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosisS E Murthy, F Chatterjee, A Crook, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1996
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosisN Kennedy, L Berger, J Curram, et al.
Thorax|July 4, 2002
Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmissionH Maguire, J W Dale, T D McHugh, et al.
BMC Medicine|October 18, 2018
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB studyM E Murphy, G H Wills, S Murthy, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 10, 2016
Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settingsW Sabiiti, B Mtafya, D Kuchaka, et al.
BMC Medicine|March 30, 2018
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB studyConor Duncan Tweed, Genevieve Helen Wills, Angela M Crook, et al.
Pageof 11